Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Carnegie Fund - Medical Sub-Fund

+ Add to Watchlist

CFE4:GR

114.4180 EUR 0.00000.00%

As of 03:36:26 ET on 05/20/2015.

Snapshot for Carnegie Fund - Medical Sub-Fund (CFE4)

Open: - High - Low: - Primary Exchange: Frankfurt
Volume: 0 52-Week Range: 72.9720 - 120.5000 Beta vs DAX: 0.6650

ETF Chart for CFE4

No chart data available.
  • CFE4:GR 114.4180
  • 1D
  • 1M
  • 1Y
114.4180
Interactive CFE4 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CFE4

Carnegie Fund - Medical Sub-Fund is an FCP incorporated in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests globally in equities of companies operating in the pharmaceutical, biotechnology and medical technology sectors.

Inception Date: Telephone: 352-40-40-30-1
Managers: ANGELICA FATOUROS
Web Site: www.carnegie.se

Fundamentals for CFE4

NAV (on 2015-05-21) 115.7700
Assets (M) (on 2015-04-30) 718.0585
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium 0.00
Average 52-Week % Premium -0.7105
Fund Leveraged N

Dividends for CFE4

No dividends reported

Performance for CFE4

1-Month -2.42% 1-Year +58.65%
3-Month +8.10% 3-Year +34.30%
Year To Date +21.59% 5-Year +23.90%
Expense Ratio -

Top Fund Holdings for CFE4

Filing Date: 04/30/2015
Name Position Value % of Total
Gilead Sciences Inc 529,672 48,393,192 6.739%
Novartis AG 410,862 37,829,568 5.268%
Johnson & Johnson 413,186 36,960,489 5.147%
UnitedHealth Group Inc 351,158 35,724,180 4.975%
Roche Holding AG 128,741 32,971,812 4.592%
Amgen Inc 228,638 32,766,658 4.563%
Pfizer Inc 1,036,315 31,619,701 4.403%
Carnegie Fund V - The Carnegie 85,642 29,719,394 4.139%
Celgene Corp 283,838 27,774,848 3.868%
Valeant Pharmaceuticals Intern 131,161 26,032,044 3.625%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil